Clinical Trial Update: A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, pharmacokinetics, and glucodynamics of intraperitoneal portal insulin U-500 in adults with Type 1 diabetes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin U-500 (insulin)

Snippet

Sponsor: Portal Diabetes, Inc. | Conditions: Type 1 Diabetes | Phase 1 | Status: RECRUITING